Surrozen Inc SRZN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:28 AM EDT
9.85quote price arrow up+0.14 (+1.47%)
Volume
10,175
52 week range
4.50 - 16.19
Loading...
  • Open9.69
  • Day High10.07
  • Day Low9.69
  • Prev Close9.71
  • 52 Week High16.19
  • 52 Week High Date03/28/24
  • 52 Week Low4.50
  • 52 Week Low Date11/09/23

Key Stats

  • Market Cap31.518M
  • Shares Out3.20M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change3.3

KEY STATS

  • Open9.69
  • Day High10.07
  • Day Low9.69
  • Prev Close9.71
  • 52 Week High16.19
  • 52 Week High Date03/28/24
  • 52 Week Low4.50
  • 52 Week Low Date11/09/23
  • Market Cap31.518M
  • Shares Out3.20M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change3.3

RATIOS/PROFITABILITY

  • EPS (TTM)-18.44
  • P/E (TTM)-0.53
  • Fwd P/E (NTM)-0.80
  • EBITDA (TTM)-36.952M
  • ROE (TTM)-80.66%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-279.23%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Surrozen Inc

 

Profile

MORE
Surrozen, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a range of organs and tissues. The Company is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with a current focus on severe liver and eye diseases. Its two lead product candidates include SZN-043 and SZN-413....
David Woodhouse Ph.D.
Non-Executive Chairman of the Board, Independent Director
Craig Parker
President, Chief Executive Officer, Director
Charles Williams
Chief Financial Officer, Chief Operating Officer, Company Secretary
Address
171 Oyster Point Blvd, Suite 400
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
VINC
Vincerx Pharma Inc
0.7119-0.0077-1.07%
COCP
Cocrystal Pharma Inc
1.85-0.05-2.63%
PYPD
PolyPid Ltd
4.58-0.13-2.68%
NRBO
NeuroBo Pharmaceuticals Inc
4.25-0.33-7.21%
GLYC
GlycoMimetics Inc
0.2899+0.0145+5.2651%